We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ORA Reorganization Includes New Office With Clinical Trial Role
ORA Reorganization Includes New Office With Clinical Trial Role
The FDA’s Office of Regulatory Affairs officially began its transition to a program-based structure May 15, including a new Office of Bioresearch Monitoring Operations that will work with each of the FDA’s product centers to ensure subject protection in clinical studies.